Trials and Tribulations of Developing a Method for Quantification of Aerosol Chamber Concentration Richard Snell, Dose Concentration Analysis GSK.

Slides:



Advertisements
Similar presentations
Bioavailability Bioavailability means the rate and extent to which the active substance is adsorbed from a pharmaceutical product and become available.
Advertisements

Quality is a Lousy Idea-
Dr. Birgit Schmauser, BfArM, Bonn
Primary Standards Is a highly purified compound that serves as a reference material in all volumetric and titrimetric methods. It must be: –1) Highly pure,
Analytical Method Development and Validation
DBS – Process & Review GHANSHYAM. 3Rs No need to explain…………… GOAL IS ANIMAL SAVING R1 REPLACEMENT R2 REFINEMENT R3 REDUCTION.
1 Method Selection and Development l Initial Considerations n What does the method need to do? 3 What analyte/s need to be assayed? 3 What range or concentration.
Errors in Chemical Analyses: Assessing the Quality of Results
Result validation. Exercise 1 You’ve done an analysis to the best of your ability using the correct procedure. Is your answer correct? possibly, hopefully.
World Health Organization
Development of an Automated, Pyridine Free Method for Aerosol Cyanide Compounds and Hydrogen Cyanide. An Alternative to NIOSH LeRoy Dobson, Chemist.
Analytical considerations Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Validation of Analytical Methods Used For Bioequivalence.
Chemometrics Method comparison
Method Comparison A method comparison is done when: A lab is considering performing an assay they have not performed previously or Performing an assay.
Unit #7 - Basic Quality Control for the Clinical Laboratory
Alfredo García – Arieta, PhD WHO Workshop on Assessment of Bioequivalence Data, 31 August – 3 September, 2010, Addis Ababa Analytical Considerations.
Quality Control In Measurements Tom Colella CLAS Goldwater Environmental Lab.
Validation of Analytical Method
Method Selection and Evaluation Method Selection and Evaluation D. Kefaya EL- Sayed Mohamed Prof. Of Clinical Pathology (Clinical Chemistry), Mansoura.
Perchlorate Analysis by Ion Chromatography The CA DHS Protocol H.S. Okamoto, D.K. Rishi and S.K. Perera.
The following minimum specified ranges should be considered: Drug substance or a finished (drug) product 80 to 120 % of the test concentration Content.
Quantitative Chemical Analysis Seventh Edition Quantitative Chemical Analysis Seventh Edition Chapter 0 The Analytical Process Copyright © 2007 by W. H.
Analytical considerations
Introduction to Analytical Chemistry Dr M. Abd-Elhakeem Faculty of Biotechnology General Chemistry Lecture 7.
Quality WHAT IS QUALITY
Quality Control Lecture 5
Understanding Your QC Presentation to: KWWOA April 15, 2015 Department for Environmental Protection Energy & Environment Cabinet To Protect and Enhance.
DEVELOPMENT OF A RP-HPLC METHOD FOR THE DETERMINATION OF METFORMIN IN HUMAN PLASMA.
Quality Assurance How do you know your results are correct? How confident are you?
5. Quality Assurance and Calibration Quality assurance is We do to get the right answer for our purpose. Have Sufficient accuracy and precision to support.
Why do we need to do it? What are the basic tools?
Prepared by :Paras Shah Guided by :Dhaval sir.  Packaging is science, art and technology of enclosing or protecting products for distribution, storage,
Evaluation of the Presage™ ST2 ELISA Jun Lu 1, David G. Grenache 1,2 1 ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 2 Department.
1 Exercise 7: Accuracy and precision. 2 Origin of the error : Accuracy and precision Systematic (not random) –bias –impossible to be corrected  accuracy.
Rachel Martin Displacement and Density. Introduction Animals are dosed by being given a specific volume of a test item (or control) formulation.
Diversity of molecules and the resulting analytical challenges CHAOTIC 24 April 2013.
Investigating Out of Specification Results
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
Stability Indicating Assays for Dose Formulation Stability Testing Teresa Fuller GSK.
Inhalation Toxicology Support Optimisation David Howie April 2014.
Titration Analysis.
Fiona McGuinness 29 April 2015 Harmonising Formulation Analysis Procedures.
Quality Control Internal QC External QC. -Monitors a test's method precision and analytical bias. -Preparation of quality control samples and their interpretation.
LECTURE 13 QUALITY ASSURANCE METHOD VALIDATION
Primary Standards Is a highly purified compound that serves as a reference material in all volumetric and titrimetric methods. It must be: –1) Highly pure,
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
Physiochemical properties of drugs Using the Sirius T3 to make measurements.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
EQUIPMENT and METHOD VALIDATION
Determination of the Solubility Product K sp of Ca(OH) 2 Experiment 13.
Diagnostic clinical chemistry
이 장 우. 1. Introduction  HPLC-MS/MS methodology achieved its preferred status -Highly selective and effectively eliminated interference -Without.
RASHTRASANT TUKADOJI MAHARAJ NAGPUR UNIVERSITY, NAGPUR
Multi-Analyte LC-MS/MS Methods – Best Practice.
Quality is a Lousy Idea-
James Byrd, Marta Kozak 28 Apr 2011
World Health Organization
Determination of Vismodegib by
Dr. Birgit Schmauser, BfArM, Bonn
Analytical considerations
Chapter 0: The Analytical Process (Example)
Quality is a Lousy Idea-
Method Selection and Evaluation
ANALYTICAL METHOD VALIDATION
World Health Organization
Introduction To Medical Technology
DICLOFENAC Validation according to requirements
Levofloxacin structural formula
Damiana Gentili Qualified Person/QU Director 09/05/2019
Presentation transcript:

Trials and Tribulations of Developing a Method for Quantification of Aerosol Chamber Concentration Richard Snell, Dose Concentration Analysis GSK

Overview Inhalation chamber concentration analysis Meth Dev and Validation of methods for aerosol chamber concentrations The problem Child  Method Development and Validation  Study Samples  The Investigation  We Have a Winner

Chamber Concentration Analysis or 14 day candidate selection studies supported including 2-3 weeks prelim phase We perform:  Concentration checks using GF/C filters  Particle size distribution analysis using washings of stainless steel foils and back-up GF/A filters Samples quantified against calibration line Quality control samples run to check performance of assay – must be within 10% of nominal concentration UPLC is the preferred system due to faster run times leading to shorter turnaround times.

Chamber Concentration Analysis - 2 Particle size distribution (PSD) solutions and GF/A Filters: Cascade impactor used in place of animal tube: contains up to 8 stainless steel foils + back-up GF/A filter Foils trap different size particles - particle size gets progressively smaller towards the rear of the impactor with GF/A filter trapping smallest particles. Foils from stages 3-8 are collected and washed with 3 mL of diluent An aliquot is analysed from each 3 mL washing solution of foils 3-8 GF/C Filters: Aerosol chamber concentration check filters used in place of animal tube Gives representation of the dose animals will be exposed to

Method Development and Validation - 1 Solubility check - 3 to 5 mg weighed, analytical diluent added in 100 µL steps (increased if no signs of going into solution) Compound dissolution assessed visually. λ max Determined by running samples prepared in diluent on a UPLC system equipped with a photo diode array (PDA) Chromatography developed Linearity investigated Interference from filters checked

Method Validation  Standard line bracketing QCs  QCs at 2 Levels – HLQ and LLQ  One QC solution prepared at each level, 10 mL added to each filter type in replicates of 6  6 replicates of blank filters  10% acceptance criteria on standards and QCs QCs re-injected with freshly prepared calibration line after storage at room temperature to establish stability Method Development and Validation - 3

The Problem Child – Method Development and Validation - 1 Solubility in initial diluent (50/50 MeCN/Water) was good Linear range of 0.25 to 30µg/mL QCs at low level failed to meet acceptance criteria. Re-run, as usual reason for failure is spiking error, or difference when spiking vastly different volumes This time marked difference between QCs containing filters and those without, ≈ 15-20%, indicating drug binding to the filters

High and low filters not exhibiting same trend, leading to a change in diluent. Consistent with binding. 40/40/20 (MeCN/MeOH/Water) was tried, resulting in the same approximate 20% difference between QCs with and without filters LLQ Raised to 0.5ng/mL Investigate different Solvents as diluent  Addition of 0.1% Formic acid to diluents  Addition of 0.05% Triflouroacetic Acid (TFA)to diluents  Aqueous Tertrahydrofuran (THF) 20%, 30% and 50% The Problem Child – Method Development and Validation - 2

The Problem Child – Method Development and Validation - 3 Addition of acid had no effect 50%, and 30% THF both had detrimental effect on chromatography 20% no effect on chromatography and appears to stop the compound binding to filters Validation run and stability runs successful METHOD VALIDATED Or so we thought...

First submission of chamber characterisation sample GF/C Filters only - run fails standard line fails and QCs outside acceptance criteria Repeated with fresh line and QCs, same issues, on closer examination line exhibits an exponential rather than linear correlation The Problem Child – Study Samples - 1

The Problem Child – Study Samples - 2 Consistent with non-specific binding Since study required Low levels, range truncated 0.5 to 8µg/mL FAILURE! No improvement on linearity. Samples sent for analysis by another group to eliminate our system

The Problem Child – Study Sample - 3 Analysis shows – Compound sticking to glass as well as filters  Worse at lower concentrations  Worsens over time

All glassware eliminated from extraction procedure, and replaced with polypropylene Raised LLQ to 1µg/mL Highlights compound still binding to filters Binding worse at higher levels indicating that in the absence of glass compound has an affinity for itself Options,  Different Filter types  Changes to diluent addition of NH 3 or TEA  Change to the way compound is trapped The Problem Child – The investigation

The use of Quartz filters were tried but did not offer any advantage The addition of 1% NH 3 to 40/40/20 (MeCN/MeOH/Water) The Problem Child – We have a Winner QC 1 GF/A QC 1 GF/C QC 30QC 30 GF/AQC 30 GF/C Mean S.D Precision (%CV) Bias % n666666

Acknowledgements Jessica Benton Aida Merchan Bob Gibbon Alan Ferrie Kay Rush